These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 34528074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
    Pan L, Du J, Liu J, Liao H, Liu X, Guo X, Liang J, Han H, Yang L, Zhou Y.
    Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
    [Abstract] [Full Text] [Related]

  • 5. A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study.
    Harigai M, Miyamae T, Hashimoto H, Yoshida A, Yamashita K, Nakaoka Y.
    Mod Rheumatol; 2023 Aug 25; 33(5):998-1006. PubMed ID: 36057089
    [Abstract] [Full Text] [Related]

  • 6. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
    Kong X, Zhang X, Lv P, Cui X, Ma L, Chen H, Liu H, Lin J, Jiang L.
    Int J Cardiol; 2018 Sep 01; 266():222-228. PubMed ID: 29729868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.
    Fujita Y, Tomiita M, Saida S, Omura S, Sato M, Otsubo Y, Takagi Y, Kano Y, Sekine K, Fukushima K, Kuwashima S, Yoshihara S.
    Mod Rheumatol Case Rep; 2023 Jan 03; 7(1):160-165. PubMed ID: 36018053
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
    Saito S, Okuyama A, Okada Y, Shibata A, Sakai R, Kurasawa T, Kondo T, Takei H, Amano K.
    Rheumatology (Oxford); 2020 Jul 01; 59(7):1617-1621. PubMed ID: 31665468
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
    Singh A, Danda D, Hussain S, Najmi AK, Mathew A, Goel R, Lakhan SE, Tajudheen B, Antony B.
    Mod Rheumatol; 2021 Jan 01; 31(1):197-204. PubMed ID: 32000551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.
    Zhou J, Chen Z, Li J, Yang Y, Zhao J, Chen H, Liu M, Sun F, Li M, Tian X, Zeng X.
    Clin Exp Rheumatol; 2017 Jan 01; 35 Suppl 103(1):171-175. PubMed ID: 28406764
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum IL-6 level trajectory for predicting the effectiveness and safety of tocilizumab in the treatment of refractory Takayasu arteritis.
    Sun X, Fang C, Jin S, Li J, Yang Y, Zeng X, Tian X.
    Eur J Intern Med; 2024 Aug 01; 126():77-82. PubMed ID: 38643043
    [Abstract] [Full Text] [Related]

  • 19. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
    Mekinian A, Biard L, Lorenzo D, Novikov PI, Salvarani C, Espitia O, Sciascia S, Michaud M, Lambert M, Hernández-Rodríguez J, Schleinitz N, Awisat A, Puechal X, Aouba A, Munoz Pons H, Smitienko I, Gaultier JB, Edwige LM, Benhamou Y, Perlat A, Jego P, Goulenok T, Sacre K, Lioger B, Hassold N, Broner J, Dufrost V, Sené T, Seguier J, Maurier F, Berthier S, Belot A, Frikha F, Denis G, Audemard-Verger A, Koné-Paut I, Humbert S, Woaye-Hune P, Tomelleri A, Baldissera EM, Kuwana M, Lo Gullo A, Mukuchyan V, Dellal A, Gaches F, Zeminsky P, Galli E, Alvarado M, Boiardi L, Muratore F, Vautier M, Campochiaro C, Moiseev S, Vieira M, Cacoub P, Fain O, Saadoun D, French Takayasu network.
    RMD Open; 2023 Jun 01; 9(2):. PubMed ID: 37321669
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.